HRGN — Harvard Apparatus Regenerative Technology Cashflow Statement
0.000.00%
Last trade - 00:00- $27.64m
- $26.28m
- $0.70m
Annual cashflow statement for Harvard Apparatus Regenerative Technology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.98 | -6.07 | -8.95 | -7.73 | -6.87 |
| Depreciation | |||||
| Non-Cash Items | 0.557 | 0.419 | 3.63 | 3.1 | 2.11 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.69 | 0.496 | -1.66 | -0.233 | 0.928 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.63 | -5.11 | -6.94 | -4.85 | -3.83 |
| Capital Expenditures | 0 | -0.005 | -0.011 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0 | 0 | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0 | -0.005 | -0.011 | 0 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.84 | 5.06 | 6.14 | 6.91 | 2.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.216 | -0.051 | -0.809 | 2.05 | -1.13 |